v3.25.3
SEGMENT INFORMATION
 9 Months Ended
Sep. 30, 2025
Segment Reporting [Abstract]  
SEGMENT INFORMATION SEGMENT INFORMATION
GE HealthCare’s operations are organized and managed through four reportable segments: Imaging, Advanced Visualization Solutions (“AVS”), Patient Care Solutions (“PCS”), and Pharmaceutical Diagnostics (“PDx”). These segments have been identified based on the nature of the products sold and how the Company manages its operations. We have not aggregated any of our operating segments to form reportable segments. A description of our reportable segments has been provided in Item 1, “Business” of our Annual Report on Form 10-K for the fiscal year ended December 31, 2024.

The Company’s organizational structure is based upon the availability of separate financial information that is evaluated regularly by the Company’s Chief Operating Decision Maker (“CODM”) for the purpose of assessing performance and allocating resources. The Company’s CODM is our Chief Executive Officer. The CODM assesses segment performance using Total revenues and an earnings metric defined as “Segment EBIT.” Segment EBIT is calculated as income before income taxes in our Condensed Consolidated Statements of Income excluding the impact of the following: Interest and other financial charges – net, Non-operating benefit (income) costs, restructuring costs, acquisition and disposition-related benefits (charges), gain (loss) on business and asset dispositions, Spin-Off and separation costs, amortization of acquisition-related intangible assets, and investment revaluation gain (loss). Segment EBIT is also used in the annual budget and periodic forecasting processes and informs the CODM in decision making regarding the allocation of resources to the segments.

Total Revenues by Segment
For the three months ended September 30
For the nine months ended September 30
2025202420252024
Total Imaging$2,349 $2,229 $6,693 $6,462 
AVS:
Procedural Guidance662 647 1,963 1,967 
Specialized Ultrasound638 569 1,866 1,725 
Total AVS
1,301 1,216 3,829 3,692 
PCS:
Monitoring Solutions
544 556 1,678 1,621 
Life Support Solutions
187 223 583 677 
Total PCS731 779 2,262 2,298 
Total PDx749 625 2,110 1,862 
Other(1)
15 15 33 39 
Total revenues$5,143 $4,863 $14,927 $14,353 
(1) Financial information not presented within the reportable segments, shown within the Other category, represents HealthCare Financial Services (“HFS”) which does not meet the definition of an operating segment.
Significant Expenses by Segment
For the three months ended September 30
For the nine months ended September 30
2025202420252024
Imaging:
Cost of sales$1,563 $1,387 $4,385 $4,118 
Other segment items(1)
546 555 1,681 1,684 
Total Imaging$2,108 $1,942 $6,066 $5,802 
AVS:
Cost of sales$655 $608 $1,890 $1,817 
Other segment items(1)
374 377 1,140 1,131 
Total AVS$1,029 $985 $3,030 $2,948 
PCS:
Cost of sales$503 $486 $1,490 $1,425 
Other segment items(1)
201 211 636 632 
Total PCS$703 $697 $2,127 $2,057 
PDx:
Cost of sales$384 $312 $1,049 $921 
Other segment items(1)
145 120 422 370 
Total PDx$529 $432 $1,472 $1,292 
(1) Other segment items for each segment includes selling, general, administrative, research, and development related expenses, as well as other segment income and expenses.

Segment EBIT
For the three months ended September 30
For the nine months ended September 30
2025202420252024
Segment EBIT
Imaging$240 $287 $627 $660 
AVS
271 232 799 744 
PCS 27 82 135 241 
PDx 220 193 638 571 
Other(1)
2 1 5 2 
761 795 2,205 2,217 
Restructuring costs(31)(22)(71)(90)
Acquisition and disposition-related benefits (charges)
(9)4 (24)7 
Gain (loss) on business and asset dispositions
— (1)5 — 
Spin-Off and separation costs(6)(56)(35)(182)
Amortization of acquisition-related intangible assets(41)(34)(116)(100)
Investment revaluation gain (loss)4 (1)96 (26)
Interest and other financial charges – net(111)(130)(335)(383)
Non-operating benefit income (costs)75 102 222 306 
Income before income taxes
$643 $658 $1,947 $1,747 
(1) Financial information not presented within the reportable segments, shown within the Other category, primarily represents HFS which does not meet the definition of an operating segment.

The following table represents the depreciation and amortization amounts reported within the Segment EBIT metric for our reportable segments. Depreciation and amortization expense related to shared property, plant, and equipment and intangibles, exclusive of acquisition-related intangible assets, has been fully allocated to our segments and those allocations are reflected in the amounts presented in the table below. These amounts are included within Cost of sales and Other segment items disclosed in the Significant Expenses by Segment table above.

Depreciation and Amortization by Segment
For the three months ended September 30
For the nine months ended September 30
2025202420252024
Imaging$57 $63 $172 $191 
AVS17 19 52 59 
PCS 14 13 41 42 
PDx 19 12 48 43 

The Company does not report total assets by segment as the Company’s CODM does not assess performance, make strategic decisions, or allocate resources based on assets.